TCR2 Therapeutics Inc. buy michaelkr
Start price
30.10.22
/
50%
€1.56
Target price
30.10.23
-
Performance (%)
-16.12%
End price
12.11.22
€1.31
Summary
This prediction ended on 12.11.22 with a price of €1.31. The price of TCR2 Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.12%. michaelkr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
TCR2 Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.665% | 1.692% | 18.093% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to michaelkr what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by michaelkr for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy TCR2 Therapeutics Inc.
In the thread Trading Tcr2 Therapeutics Inc.
Buy beendet
Stopped prediction by michaelkr for TCR2 Therapeutics Inc.
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.89
02.10.22
02.10.22
-
02.10.23
02.10.23
-11.24%
16.10.22
16.10.22
Risky Investment
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.38
09.09.22
09.09.22
-
09.09.23
09.09.23
-6.96%
18.09.22
18.09.22
Risky Investment
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.92
23.01.22
23.01.22
-
23.01.23
23.01.23
-7.53%
06.02.22
06.02.22
Risky Investment